We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
8 hedge funds and large institutions have $972K invested in Atossa Therapeutics in 2013 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
523% more capital invested
Capital invested by funds: $156K → $972K (+$816K)
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
167% more funds holding
Funds holding: 3 → 8 (+5)
Holders
8
Holders Change
+5
Holders Change %
+166.67%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$249K |
| 2 |
Goldman Sachs
New York
|
+$170K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$131K |
| 4 |
Jane Street
New York
|
+$105K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$26.2K |
Top Sellers
| 1 |
Barclays
London,
United Kingdom
|
-$14K |
| 2 |
Citigroup
New York
|
-$1K |